XML 11 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Profit or Loss and Other Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Consolidated Statements Of Profit Or Loss And Other Comprehensive Income Abstract          
Revenues from proprietary products $ 25,580 $ 17,123 $ 67,198 $ 57,316 $ 75,521
Revenues from distribution 6,637 5,911 16,702 14,857 28,121
Total revenues 32,217 23,034 83,900 72,173 103,642
Cost of revenues from proprietary products 13,151 12,078 37,856 35,605 48,194
Cost of revenues from distribution 6,196 5,226 14,632 12,835 25,120
Total cost of revenues 19,347 17,304 52,488 48,440 73,314
Gross profit 12,870 5,730 31,412 23,733 30,328
Research and development expenses 3,118 2,545 10,181 7,909 11,357
Selling and marketing expenses 3,843 1,256 10,435 3,803 6,278
General and administrative expenses 3,165 2,691 9,481 8,803 12,636
Other expenses 182 42 801 612 753
Operating income (loss) 2,562 (804) 514 2,606 (696)
Financial income 29 68 32 277 295
Income (expenses) in respect of currency exchange differences and derivatives instruments, net 163 (48) 756 74 (207)
Financial Income (expense) in respect of contingent consideration and other long- term liabilities. (2,049) (5,924) (947)
Financial expenses (211) (61) (583) (178) (330)
Income before tax on income 494 (845) (5,205) 2,779 (1,885)
Taxes on income 10 60 345
Net Income (loss) 484 (845) (5,265) 2,779 (2,230)
Gain (loss) on cash flow hedges (46) 68 (830) 25 185
Net amounts transferred to the statement of profit or loss for cash flow hedges 231 (91) 519 (347) (488)
Remeasurement gain (loss) from defined benefit plan (59) 361 171
Total comprehensive income (loss) $ 610 $ (868) $ (5,215) $ 2,457 $ (2,362)
Basic net earnings per share (in Dollars per share) $ 0.01 $ (0.02) $ (0.12) $ 0.06 $ (0.05)
Diluted net earnings per share (in Dollars per share) $ 0.01 $ (0.02) $ (0.12) $ 0.06 $ (0.05)